Use For Alluvi Retatrutide Pens
Retatrutide works in the treatment of obesity by targeting three different hunger regulating hormones: – GIP (gastric inhibitory peptide or glucose-dependent insulinotropic polypeptide) is an incretin hormone that is released from the gut after eating. It stimulates the beta-cells in the pancreas to secrete insulin. – GLP-1 (glucagon-like peptide-1) is also an incretin hormone that stimulates the beta-cells to secrete insulin.
Alluvi Retatrutide Pens for sale Online glucagon is a hormone secreted from the alpha-cells in the pancreas. It stimulates glucose production in the liver and helps maintain adequate plasma glucose concentrations. The drug has been nicknamed ‘triple G’ because it is an agonist of all three receptors.
Dosing & Administration
Although not standardized yet, available product labeling (e.g. from Alluvi’s product description) outlines typical pen use:
Start at ~2.5 mg, gradually increase to up to ~10–12 mg weekly (e.g. 2.5 → 5 → 7.5 → 10 mg) depending on tolerance and weight loss goals .
Patients should rotate injection sites (arm, thigh, abdomen), prime the pen before first use, use a new needle each time, and store correctly — refrigerate at 2–8 °C before use, room temperature up to 4 hours or up to 15 °C after opening, keep capped, do not freeze or keep needle attached . Alluvi Retatrutide Pens For Sale USA
Logs of dose and date are advised; titration every ~4 weeks is typical based on early trials protocols .